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Abstract
The impact of infectious disease outbreaks and pandemics on the health systems could be
alarming especially when there is an overlap in clinical manifestations of two infectious
conditions. Despite the remarkable progress in reducing the burden of malaria in Africa since
2000, the COVID-19 pandemic has impacted the malaria control program. This paper describes
the impact of the COVID- 19 pandemic on the health service delivery in Guinea and its
consequences on malaria control programs before and during the COVID 19 pandemic. This
paper aims to assess the impact of the COVID 19 pandemic on the malaria control program
between 2020 to 2021 in the Regional Hospital of Kindia and identify its deficiencies to suggest
effective recommendations. The study also compares the clinical manifestation of malaria and
COVID 19 disease.
Keywords: Malaria, Covid 19, Impact, Control, Recommendations.
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CHAPTER 1: INTRODUCTION
Coronavirus infectious disease (COVID-19) is an outbreak caused by a novel coronavirus
called severe acute respiratory syndrome. Severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) was announced in Wuhan, China, in early December 2019, and the disease was
later referred to as COVID-19 (Wei M et al., 2020). The COVID-19 disease is mainly
transmitted through three principal ways of exposure: inhalation of droplets and aerosol particles,
deposition of respiratory droplets and particles on exposed mucous membranes in the mouth
(nose, or eye by direct splashes and sprays), and direct contact of the mucous membranes with
soiled hands by virus-containing respiratory fluids or indirectly by touching surfaces with the
virus on them (Wei M et al., 2020). COVID-19 symptoms appear within five days of infection
and are characterized by fever, coughing, fatigue, headaches, arthralgia, myalgia, nausea,
vomiting, and loss of smell. The disease can be asymptomatic sometimes (Hussein et al.,2020).
According to Rogerson and al., the COVID-19 pandemic has affected millions of people,
hundreds of thousands of deaths, and led to socio-economic disruption, the limitation in the
manufacturing, the supply, and the delivery of malaria control resources such as drugs, bed nets,
rapid diagnostic test kits, and insecticide within Africa due to movement restrictions. These
restrictions contribute to a remarkable decrease in insecticide-treated net (ITN) distribution
(75%) associated with a 75% decrease in access to artemisinin combination therapies (ACT).
The malaria prevalence and mortality rate were respectively estimated to be 22% and 769,000
per year including 70% of children under 5 years old in 2020 (Rogerson et al.,20 20).
In addition to the high prevalence and mortality rate, the socio-economic impacts, and the
disruption of the supply chain of malaria control resources, the COVID 19 pandemic also
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contributes to the limited access to primary care and hospitalization, the disruption of the
workforce, health-system administrators, and logistics in Africa (Weiss et al. 2021).
Malaria disease is caused by parasites of the genus Plasmodium transmitted through the
bite of infected female Anopheles mosquitoes. Malaria symptoms often appear 10-15 days after
the mosquito bite and are characterized by a fever, headache, chills, sweating, fatigue, and
diarrhea (Hussein et al.,2020). Malaria represents the leading cause of morbidity and mortality in
sub-Sahara Africa. According to Ajayi et al. in 2020, 228 million cases and 405, 000 malariarelated deaths occurred globally with 93% of cases in Sub-Sahara Africa (Ajayi et al. 2020).
In Guinea, malaria represents the leading cause of mortality and morbidity. The incidence
of malaria cases is estimated at 87 per 1,000 and the overall mortality rate of malaria is 41% for
adults over 15 years (52% males, 30% females), and infants and children under five years old
mortality rates are respectively 44 and 88 per 1,000 live births in 2016(Cherif et al.,2021).
Before March 13, 2020, the progress in insecticide-treated net (ITN) distribution, malaria
testing, and malaria treatment programs considerably reduced the burden of malaria in Guinea
(Cherif et al.,2021). From 2016 to 2019. the household ownership of at least one ITN increased
from 47% to 84% while the proportion of households with at least one ITN for every two people
increased from 10% to 48%. (Severe Malaria Observatory,2021). The percentage of pregnant
women who received two or more doses of intermittent preventive treatment Sulfadoxinepyrimethamine (SP) in pregnancy during their last pregnancy in the last two years increased from
49% to 62% and from 30–to 36% for those who received three or more doses. About 2.7 million
courses of ACT and 3 million rapid diagnostic tests (RDT) were annually distributed (Severe
Malaria Observatory,2021). These major interventions of malaria control programs reduced the
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prevalence and mortality rate of malaria. The prevalence of malaria was reduced by 12.6% (from
340 to 297 per 1000 of the population at risk) and the mortality rate fell by 12% (from 0.73 to
0.64 per 1000 of the population at risk). The prevalence of malaria in children under 5 years and
pregnant women was respectively estimated to be 37.3 % and 3.9 % (Severe Malaria
Observatory,2021). Since the official declaration of the COVID-19 disease in Guinea on March
13, 2020, the ongoing pandemic continues to contribute to the disruption of malaria control
activities affecting the burden and the treatment of malaria, the decrease in health facilities, and
healthcare professional utilization in Guinea. The number of suspected malaria cases increased
by 2.6% (from 3,334,355 in 2019 to 3,422,309 in 2020) and the number of RDT confirmed
positive cases increased by 10.9% (1,801,694 vs 1,998,329) (Cherif et al. 2021).
Based on the health facilities’ utilization, the COVID-19 pandemic contributes to a
decrease of 71.1% (320 patients) in consultation and 75% (35 patients) in hospitalization in the
cardiology service of the Ignace Deen National Hospital of the Conakry University Hospital,
Guinea from March to April 2020 (Barry et al., 2021).
In the Regional Hospital of Kindia, the high mortality and morbidity from malaria during
the COVID-19 pandemic is due to poor quality of equipment, poor access to diagnosis,
treatment, healthcare services, and professionals. This paper aims to assess the impact of the
COVID-19 pandemic on the burden of malaria disease, evaluate and identify the deficiencies of
malaria control programs during COVID-19 pandemic restrictions, and suggest effective
recommendations that could improve malaria control programs based on the literature.
Specific aims
Aim 1: Describes malaria-related outcomes during the pandemic and compares them to historical
patterns for malaria services performance.
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Aim 2: Assess access to and provision of malaria-related services during the COVID-19
pandemic and compares them to the historical patterns of malaria services performance
Aim 3: Apply analytic outputs to identify potential areas for malaria program improvement in the
pandemic setting
Significance
The scientific premise of this research has been based on the concern of the overlap of COVID19 symptoms and malaria leading to delay in treatment, the limited equipment and resources for
healthcare workers, inadequate infrastructure to address malaria, and other infectious diseases,
poor access to healthcare services and health professionals during the pandemic, and the lack of
scientific study related to such topic at the Regional Hospital of Kindia.
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CHAPTER 2: METHODOLOGY
This study is a retro-prospective descriptive analysis. The data used in this study were collected
during routine public health reporting from the Regional Hospital of Kindia. This constituted
monthly, aggregate reports of de-identified information including malaria, and COVID-19 cases.
Dependent variables
Dependent variables included at-risk classification (age ≤ 5 years, age >5, pregnant
women), the number of malaria cases ( outpatients, hospitalized persons, deaths ), the number of
COVID-19 cases(at Kindia and nationally), the number of ITN distributed, the number of SP
received by pregnant women, the number of people reached by the awareness sessions
(awareness rate), the number of first antenatal consultations, the number of cases tested positive
by microscopy and those positive(Microscopy +), the number of cases tested by RDT positive
and those positive, respiratory infections identified (cough, cough > 2 weeks, pneumonia and
severe pneumonia), and medical supplies consumed(ACT, Quinine, RDT ).
Independent Variables: Date expressed in year-month format.
Inclusion criteria
Eligibility criteria included participants received in the Regional Hospital of Kindia with
all malaria positive cases (suspected and confirmed) before the COVID-19 pandemic (March 1,
2019, through February 29, 2020) and during the COVID-19 pandemic (April 1, 2020, through
March 31, 2021); all COVID -19 positive cases that were received from April 1, 2020, through
March 31, 2021.
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Data collection
For the analysis, data were collected from March 1, 2019, to March 31, 2021, so that a
sufficient period both before (March 1, 2019, through February 29, 2020, representing 366 days
of observation) and during the COVID-19 crisis (April 1, 2020, through March 31, 2021,
representing 365 days of observation). March 2020 was excluded from analyses because that was
the month in which the pandemic was recognized in Guinea, and to avoid overlap. Data
collection included 17,403 malaria cases before the COVID-19 pandemic, and 32,467 malaria
cases during the pandemic based on positive results from both microscopic and RDT performed
on pregnant women, children ≤ 5 years, and patients over 5 years old.
Study Procedure
To assess the impact of the COVID-19 pandemic on the malaria control program in the
regional hospital of Kindia, a descriptive analysis was conducted on each variable over time
(monthly) and examined individually and as an aggregate. Multiple time series were constructed
to understand the burden of reported malaria cases across the time and COVID-19 cases or case
rates (as reported). Descriptive and summary statistics were conducted to describe malaria
service, prevention, and malaria treatment utilization before and after the onset of COVID-19. In
addition, the Wilcoxon Signed Rank Test was employed to analyze the changes observed
between the period before COVID-19 and during the COVID-19 pandemic. Statistical
significance was defined as P < 0.05 and SAS version 9.4 was used for statistical analysis.
FACILITIES
Kindia Region is limited to the northwest by the region of Boké, to the northeast by the
region of Labe and Mamou, to the southeast by Sierra Leone, and the southwest by the Conakry
region, and by the Atlantic Ocean (Figure 1). Regional Hospital Kindia (HRK) called « Hospital

10
Regional Alpha Oumar Diallo de Kindia » is a public hospital located in the Kindia Region 135kilometer squares from Conakry, the capital of Guinea. HRK covers three other hospitals
(Foreciah, Coyah, Telimele, Dubreka). The Regional Hospital of Kindia has a capacity of 120
beds distributed to four medico-techniques and six medical structures including the Epidemic
Treatment Center (ETC). ETC of Kindia with a capacity of 15 beds is constituted of one trial
center, three hospitalization rooms, a consultation room, and the annex that includes toilettes,
laundry, a mortuary room, and an incinerator. This facility has three objectives: research,
healthcare services, and training. The TC has seven (07) staff that include two (02) physicians,
four (04) nurses, and one (01) maintenance person.

Figure 1: Geographic Situation of Regional Hospital of Kindia
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CHAPTER 3: RESULTS
1-MALARIA SERVICE UTILIZATION BEFORE AND DURING THE COVID-19
PANDEMIC
Malaria service utilization across the study period is shown in Figure 2 below. The
multiple times series plots show an increase in the number of consultations (overall malaria
cases) with multiple fluctuations before the COVID-19 pandemic (from January 2019 through
February 2020) while the number of hospitalized patients slightly increases from April 2019 to
December 2019. During the COVID-19 pandemic, the number of consultations drastically
decreased from March 2020 to Jun 2020 and then increased while hospitalizations were
relatively stable but higher from Nov 2020-Mar 2021 compared to Mar -Oct 2020 period.

Figure 2: Malaria Sevice utilization before and during the COVID-19 pandemic.

2- MALARIA AT-RISK CLASSIFICATION BY CATEGORY
In total, combining both microscopic and RDT results 17,403 malaria cases were
confirmed before the COVID-19 pandemic, and 32,467 malaria cases were confirmed during the
pandemic. This represents a test positivity rate of 93% (17,403/18,683) in the pre-pandemic
period and 99.86% (32,467 /32,512) in the pandemic period. Before the COVID-19 pandemic,
6178 (35%) of malaria cases occurred in children aged 5 years or younger, 9,002 (52%) among
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patients over 5 years old, and 2,223 (13%) in pregnant women. During the COVID-19 pandemic,
6,743 (21%) malaria cases occurred in children aged 5 years or younger, 643 (2%) among
patients over 5 years of age, and 25,081(77%) occurred in pregnant women. Malaria-related
deaths of both patients aged 5 years or younger, and over 5 years increased from 27 (42%) to (38
46%), and 25 (38%) to 33 (40%) respectively. However, the number of pregnant women who
died from malaria declined from 13(20%) to 11(13%). The case fatality rate (CFR) in patients
over 5 years was 5.13%. Patients ≤ 5 years and pregnant women had a CFR equal to 0.56% and
0.04% respectively (Table 1). To test the statistical significance of the changes in malaria cases
and deaths among at-risk populations in Kindia, a Wilcoxon Signed Rank Test was performed.
This study revealed a statistically significant increase in malaria cases diagnosed among pregnant
women (Z=2.21, P=0.03). However, the change observed among patients aged 5 years or
younger (Z=1.12, P=0.26) and older than 5 years (Z=1.43, P=0.15) did not reach statistical
significance. A statistically significant change was observed in malaria-related deaths among
both patients aged 5 years or younger (z=2.72, P=0.01) and those over 5 years of age (z=2.4015,
P=0.02). Nevertheless, no statistically significant differences were observed among pregnant
women (Z=0.34, P=0.74).
Table 1: Malaria case counts and distribution by age and Pregnancy status
Date
Before COVID-19

During COVID-19

At-risk Classification

Cases

Percentage

Deaths(%)

CFR(%)

≤ 5 years

6,178

6,178(35%)

27(42%)

0.44

Over 5 years

9,002

9,002(52%)

25(38%)

0.28

2,223

13(20%)

0.58

6,743

2,223(13%)
6,743(21%)

38(46%)

0.56

643

643(2%)

33(40%)

5.13

25,081

25,081(77%)

11(13%)

0.04

Pregnant women
≤ 5 years
Over 5 years
Pregnant women

3-MALARIA TESTING AND TREATMENT UTILIZATION
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In malaria testing and treatment utilization activities, the disruption of malaria service
was assessed both before and during the COVID-19 pandemic. There was an increase in the
distributions of ACT (449 vs 672), Quinine (110 vs 476), and RDT (223 vs 350) during the
COVID-19 pandemic. Using Wilcoxon signed-rank test, statistically significant increases in the
ACT (Z=2.40, P=0.0162) and Quinine consumption (Z=3.70, P=0.0002) were observed during
COVID-19. Nevertheless, the change in RDT consumption did not reach statistical significance
(Z=1.73, P=0.08) (Table3).
Table 3: Malaria Diagnostic and Treatment Supplies Consumed by Month
Date

Items

Before COVID-19

ACT
Quinine
TDR
ACT
Quinine
TDR

During COVID-19

Months Minimum
14
14
14
13
13
13

67.00
0.00
58.00
120.00
160.00
82.00

Mean

Maximum

448.50
110.14
223.29
671.54
475.38
349.46

820.00
430.00
427.00
1102.00
1290.00
1190.00

4-PREGNANCY AND MALARIA PREVENTION
A malaria service disruption was assessed based on the number of ITNs distributed, the
number of SPs distributed, awareness rates, and the first ANC. Results indicate that awareness
rates decreased (593 vs 552) the number of ITNs decreased (113 vs 90), and the first ANC
decreased (165 vs129) during the COVID-19 pandemic. Also, we noted a decrease in the number
of pregnant women receiving SP in each of the four groups: 1 dose of SP distribution (140
vs139), 2 doses of SP distribution (112 vs 109), 3 doses of SP distribution (101 vs 93), and 4
doses of SP distribution (from 77 vs 68). The Wilcoxon Signed Rank Test was used to determine
whether COVID-19 affected awareness rates, ITN distribution, SP distribution, and the first. The
test revealed a statistically significant decrease in 3 doses of SP distribution (101 vs 93) (Z=1.99, P= 0.05), and the first ANC (165 vs129) (Z=-3.26, P=0.001) (Table 2, Figure 5). However,
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there was a statistically non-significant decline in ITN distribution (Z=-1.24, P= 0.22), awareness
rate (Z=-1.34, P=0.18), one dose of SP (Z=-1.14, P= 0.25), two doses of SP (Z=-1.04, P= 0.30),
and four doses of SP distribution (Z=-0.85, P= 0.40).
Table 2: Pregnancy and Malaria Prevention
Date

Before COVID-19

During COVID-19

Variable
First ANC

Months
14

Minimum
134.00

Mean
165.43

Maximum
190.00

Awareness rate
ITNs distributed
1 dose of SP
2 doses of SP
3 doses of SP
4 doses of SP
First ANC

14
14
14
14
14
14
13

413.00
20.00
29.00
42.00
25.00
23.00
35.00

592.64
112.79
139.86
112.00
101.29
77.43
128.92

694.00
203.00
179.00
146.00
123.00
111.00
168.00

Awareness rate
ITNs distributed
1 dose of SP
2 doses of SP
3 doses of SP
4 doses of SP

13
13
13
13
13
13

356.00
46.00
96.00
90.00
72.00
40.00

551.54
90.46
139.08
109.23
93.08
68.38

688.00
128.00
157.00
123.00
115.00
123.00

Figure 5: Pregnancy and Malaria Prevention
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5-COMPARISON OF MALARIA CASES TO COVID -19 CASES
The graph shows a slight increase in the number of malaria cases from March 2020 to
April 2020 and then drastically decreased from April 2020 to Jun 2020 while the number of
COVID-19 cases increased. From April 2020 to February 2021, the number of COVID-19
cases decreased with multiple fluctuations (Figure 3).

Figure 3: Comparison of Overall Malaria cases to COVID-19 cases

6-DISTRIBUTION OF RESPIRATORY INFECTIONS
The descriptive statistics indicated an increase in respiratory infections between the pre
and during the COVID-19 pandemic. According to the data, the number of coughs, coughs >2
weeks, pneumonia, and severe pneumonia respectively increased (2 vs 4), (1vs 3), (0 vs 2), and
(5 vs 8) (Table 4). The Wilcoxon Signed-Rank Test revealed statistically significant positive
changes in cough >2 weeks (Z=3.50, P=0.0005), and in pneumonia (Z=2.5860, P=0.01). In
contrast, the change in cough (Z=1.85, P=0.06) and severe pneumonia (Z=1.22, P=0.22) was not
statistically significant.
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Table 4: Descriptive Statistic of Respiratory Infections
Date
Before COVID-19

Variables
Cough
Cough > 2 weeks
Pneumonia
Severe Pneumonia
During COVID-19 Cough
Cough > 2 weeks
Pneumonia
Severe Pneumonia

N
14
14
14
14
13
13
13
13

Minimum
1.00
0.00
0.00
0.00
1.00
2.00
0.00
0.00

Mean
2.43
1.21
0.14
4.93
3.62
2.62
1.62
7.85

Maximum
3.00
2.00
2.00
12.00
7.00
4.00
5.00
20.00

7- COMPARISON OF KINDIA COVID-19 CASES TO NATIONAL COVID-19 CASES
Both Kindia COVID-19 and National COVID-19 cases increase exponentially from
March 2020 to April 2020 and then the number of Kindia COVID-19 cases decreases drastically
with multiple fluctuations while the number of National COVID-19 cases continues to increase
(Figure 4).

Figure 4: Comparison of Kindia COVID-19 cases to National COVID-19 cases
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CHAPTER 4: DISCUSSION
In this study, we sought to assess the impact of the COVID-19 pandemic on the burden of
malaria, evaluate and identify the deficiencies of malaria control programs and suggest effective
recommendations based on the literature. In our study, we observed an increase in total malaria
cases (overall consultations) with multiple fluctuations in the period before the COVID-19
pandemic (from January 2019 through February 2020) while hospital stays increased slightly
from April to December. During the COVID-19 pandemic, malaria cases decreased drastically
from March 2020 to June 2020 and then increased while hospitalizations were relatively stable
but higher from Nov 2020 to Mar 2021 compared to Mar -Oct 2020 period (Figure 2). In 2021,
Barry et al. also noted that the number of consultations and hospitalizations decreased during the
COVID-19 pandemic at Ignace Deen National Hospital Conakry (Barry et al., 2021). A decrease
in hospital admissions might be explained by two factors. On the one hand, people may fear
getting sick from the virus of COVID-19 after visiting health care facilities. On the other hand,
Guinea has a sad history of the Ebola epidemic that led to more than 2,544 deaths in 2014
(Migliani et al., 2016).
In this study, malaria cases among pregnant women increased significantly(P=0.0272).
During the COVID-19 pandemic, pregnant women experienced an increase in malaria cases
from 2,223 (13%), to 25,081 (77%). The number of malaria cases diagnosed among patients
under 5 years or younger and over 5 years respectively decreased from 6,178(35%) to
6,743(21%), and 9,002(52%) to 643(2%). The number of malaria-related deaths of both patients
aged 5 years or younger, and those over 5 years increased from 27 (42%) to 38 (46%), and 25
(38%) to 33 (40%) respectively. In our study, across time points malaria cases and deaths were
higher among children aged 5 and younger than those aged over 5 years of age, though there
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appears to be a severe negative observation bias among those aged over 5 years in the COVID19 period. Also, relative burden of malaria-related deaths among pregnant women declined from
20% to 13% of total malaria mortality burden, In our study, we found that the CFR was higher in
patients over 5 years compared to those ≤ 5 years (Table 1). Weiss et al. 2020, estimated an
increase in malaria cases by 21.5% (16.3/27.9 and malaria-related deaths by 328.7(311.6/350.2)
because of the COVID-19 pandemic in 2020 (Weiss et al. 2021). Heuschen et al. found that there
were 46,693 malaria cases confirmed in pregnant women increased by 39% in 2021 (Heuschen
et al., 2021). While reasons for the high number of malaria cases and deaths in children aged 5
years or younger compared to patients over 5 years are difficult to extrapolate in the setting of
severe observation bias, that under 5 years mortality is high in malaria is well established.
Furthermore, after several episodes of malaria, patients over 5 years old can develop immunity to
the disease (Abossie et al.,2020). Not knowing the distribution of ages among those patients over
5 years makes extrapolations regarding underlying conditions difficult (Onder et al., 2020).
While pregnant patients after 26 weeks of intra-uterine pregnancy are often considered to be at
higher risk for consequences from infectious diseases, the disruption of women's access to and
delivery of ANC services allowing prevention may account for this.
Based on the malaria testing and treatment service utilization activities between and
during the COVID-19, we found an increase in the ACT, Quinine, and RDT consumption during
the COVID-19 pandemic (Table 3). Similarly, Afai et al. found that the number of people tested
with RDT for malaria increased by 39% (190,370/266,733) during COVID-19 (Afai et al., 2020).
Contrary to Namuganga and al. 2021, the number of malaria cases tested with RDT decreased
from 85.4% to 80.3 % during the COVID-19 crisis (Namuganga et al.,2021). In this instance, the
high availability of ACTs and RDTs can be explained by the fact that the Regional Hospital of
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Kindia benefited from important free RDT supplies and so stockpiling provided by the U.S.
President’s Malaria Initiative Program before the COVID-19 pandemic occurrence.
Our findings indicate that malaria prevention measures decreased substantially during the
COVID-19 pandemic. We found a statistically significant decrease in the 3 doses of SP
distribution and the number of 1st ANC. We also observed a statistically non-significant decline
in the distribution of ITNs, awareness rate, 1 dose of SP, 2 doses of SP, and 4 doses of SP. These
findings are consistent with the study conducted by Seboka et al. in 2020 which also indicated a
decrease in ITN distribution in 2021 (Seboka et al., 2020). In contrast, Weiss et al. observed an
increase in ITN distribution in 2021, from 32.5% to 72.7% (Weiss et al., 2021). On the one hand,
this decrease can be explained by the fact that limited resources (including human resources) for
malaria control were allocated to COVID-19 pandemic management, leaving a relatively small
number of resources to address essential public health measures during the pandemic. On the
other hand, Guinea did not hold a mass ITN campaign in 2020. In addition, the routine
distribution of ITNs during antenatal consultations (ANC) was disrupted by the COVID-19
pandemic due to the fear of getting it, as well as the initial disruption of information about the
disease and intermittent preventive treatment.
In this study, we found an exponential increase of both Kindia COVID-19 and National
COVID-19 cases from March 2020 to April 2020, and then the number of Kindia COVID-19
cases drastically decreased with multiple fluctuations while the number of National COVID-19
cases continue to increase (Figure 4). The decrease of Kindia COVID-19 cases at ETC can be
explained by the fact that the local ETC frequently evacuated all severe COVID-19 cases to the
National ETC due to the lack of adequate equipment and qualified staff for serious COVID-19
cases treatment. This study revealed major challenges in determining the demographic
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characteristics of malaria patients. Therefore, future community-based studies are essential to
better understand the impact of the pandemic on malaria burdens and to evaluate how the
structure and staff function.
There are two major strengths of this study: well-delineated descriptive analytics of data
correlation with the existing literature. The current study has limitations that should be taken into
consideration when interpreting its results. In the first place, the data set did not allow gender or
other non-age demographic information to be assessed as variables. Second, the dataset was
driven by reporting practices that might incorporate observation and misclassification biases,
particularly in the setting of suspect malaria cases and COVID-19 cases. However, we believe
our findings will greatly enhance our understanding of the impact of COVID-19 on malaria
control programs.
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CONCLUSION
In conclusion, this study shows that the COVID-19 pandemic negatively impacted the
malaria control programs in the Regional Hospital of Kindia, which caused a decrease in
awareness rate, ITN, SP distribution, and the first ANC after the pandemic occurrence. Further,
the pandemic also impacted malaria service utilization through the low number of consultations
and the number of hospitalizations. However, the COVID-19 pandemic had not significantly
impacted malaria treatment and testing utilization. Interventions and strategies focused on
reducing and controlling the malaria disease burden, mainly in the malaria-endemic settings,
must seriously be considered during a pandemic response. A continued malaria service during
and after the pandemic represents a necessity for an effective malaria control program.
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RECOMMENDATION
This study revealed that malaria prevalence and malaria-related deaths were high among
pregnant women, patients aged 5 years or younger, and those over 5 years. To reduce malaria
transmission, malaria control programs should ensure that at-risk populations have access to
ITNs and utilize them effectively. If mass ITN distribution campaigns cannot be carried out as
planned, priority should be given to areas with the highest malaria burden (Alliance for Malaria
Prevention, 2020). To integrate COVID-19 with malaria control, existing systems need to be
supported: door-to-door distribution of ITNs or integration with economic palliatives distribution
to reach a larger number of people. Distributors need to be provided with protective measures
against the COVID-19. The distribution of malaria commodities in rural and hard-to-reach areas
can be accomplished using the existing infrastructure used for the distribution of COVID-19
supplies. To ensure global health security, proactive surveillance for COVID-19 should be used
to enhance surveillance of malaria and other diseases (Ajayi et al., 2020). Provide periodic
malaria chemoprevention (SMCP) and intermittent preventive treatments to all children aged 5
years or younger during malaria season and intermittent preventive care with sulfadoxinepyrimethamine (SP) to pregnant women to reduce malaria prevalence and mortality
(WHO,2020). In addition, we noticed that pregnant women have difficulty accessing ANC
services in the pandemic setting. The government should support pregnant women to remotely
access the ANC during the COVID-19 pandemic by providing access to mobile devices and
establishing regulations to maintain their privacy (Uwambaye et al.,2020). Furthermore, the
study revealed a reduction in hospital admissions. Education and engagement of the community
are crucial to reinforce messages about malaria prevention, diagnosis, and treatment. Providing
prompt diagnosis and treatment of malaria requires the establishment of adequate health services
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and the training of health workers to ensure a safe working environment and appropriately
resourced facilities (Rogerson et al., 2020). There were major challenges in identifying the
demographic characteristics of malaria patients in this study. Future community-based studies
are recommended to better understand the impact of the COVID19 pandemic on malaria burdens
and to assess how the structure and staff function.
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APPENDIX A: SUMMARY OF LITERATURE
Title: Commonalities, Intersections, and Implications for Sustaining Malaria Control.
Authors: Ajayi, I. O., Ajumobi et al.
Abstract: In this article, the authors describe the consequences of the infectious disease outbreak
of COVID 19 pandemic on the health system in Afrique du in presence of several health
conditions The paper focuses on the consequences of Ebola and COVID 19 pandemic on the
malaria control program in West and Central African countries respectively between 2014 and
2016 and between 30 January 2020 and March 11, 2020. The purpose of this study is to compare
the COVID19 pandemic and malaria and discuss implications and recommendations to improve
malaria control programs during the ongoing COVID-19 pandemic.
Keywords: COVID-19; consequences; integrated control; malaria; pandemic.
Title: Malaria epidemiology and anti-malarial drug efficacy in Guinea: a review of clinical and
molecular studies
Authors: Cherif, M.et al.
Abstract: This study describes the mortality and morbidity of malaria and its transmission in
Guinea. This study provides strong evidence of the effectiveness of the treatment against the
Plasmodium falciparum as the primary parasite species based on Chloroquine (CQ) as the firstline drug in the past for uncomplicated P. falciparum in Guinea until 2005, and then artemisininbased combination therapy (ACT) as of current therapy. This study reviewed the therapeutic
efficacy of CQ and artemisinin-based combinations and found against CQ, a failure rate of 27%
(12/44) was reported in a study in 1992; a median failure rate of 15.6% [range: 7.7–28.3; 8
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studies] was observed during 1996–2001, and 81% (17/21) of the patients failed to clear
parasitemia in a study conducted in 2007. In addition, the study describes the impact of the
COVID 19 pandemic on the malaria control program.
Keywords: Malaria, Guinea, Resistance, Artemisinin-based combination therapy,
Efficacy, Plasmodium falciparum
Title: African malaria deaths set to dwarf covid-19 fatalities as pandemic hits control efforts,
WHO warns
Authors: Dyer, O
Abstract: This study alerts the possible increase in the mortality rate of malaria due to the
impact of COVID 19 on its prevention and treatment efforts in sub-Saharan Africa. The paper
related that 1.5 billion malaria cases and 7.6 million deaths have been averted since 2000 and
compared malaria’s mortality rate to the mortality related to the COVID 19 pandemic. The
purpose of this article is to describe the consequences of COVID 19. The author also stated the
prospective vaccination in the second quarter of 2021.
Keywords: Malaria, Mortality, COVID 19, Consequences, Vaccination.
Title: Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity,
and mortality in Africa: a geospatial modeling analysis.
Authors: Weiss, D., Bertozzi-Villa, et al.
Abstract: The study describes the burden of malaria in Africa since 2000 and the impacts of the
COVID 19 pandemic on the malaria control program. The study has for purpose to evaluate the
incidence and mortality of malaria during the COVID 19 pandemic.
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Keywords: Malaria, Incidence, Mortality, COVID 19, Intervention.
Title: Malaria death toll to exceed COVID-19 in sub-Saharan Africa
Authors: Kelland, K.
Abstract: The study describes the mortality of malaria and its transmission during the COVID
19 pandemic in sub-Saharan Africa.
Keywords: Death, Malaria, COVID-19, transmission.
Title: Malaria facts and Situation in Guinea
Authors: Severe Malaria Observatory
Abstract: The article provides evidence of the burden of malaria between 2016 and 2019 and
found that the case burden for malaria fell by 12.6% (from 340 to 297 per 1000 of the population
at risk), while deaths fell by 12% (from 0.73 to 0.64 per 1000 of the population at risk. The
authors also describe the progress made in malaria prevention among vulnerable populations
based on the use of insecticide-treated nets (ITNs), and sulfoxide-pyrimethamine (SP).
Keywords: Malaria, Burden, prevention, Death.
Title: Identifying and combating the impacts of COVID-19 on malaria
Authors: Rogerson, S.J. et al.
Abstract: This article describes the occurrence of infections and mortality rates related to COVID
-19 pandemic restrictions. The purpose of this study is to demonstrate how the pandemic
impacted the treatment, prevention, and control of malaria
Keywords Infections, malaria, COVID 19, mortality, prevention
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Title: Impact of the COVID-19 pandemic on the activities of the cardiology service of the
Ignace Deen National Hospital of the Conakry University Hospital.
Authors: Barry IS, et al.
Abstract: The purpose of this descriptive retrospective study is to assess the impact of the
COVID-19 pandemic on the activities of the cardiology service of the Ignace Deen National
Hospital of the Conakry University Hospital. The study focused on the consultation and
hospitalization activities in the cardiology service of the Ignace Deen National Hospital of the
Conakry University Hospital. The study compares the frequency of consultations and
hospitalizations before (January and February 2020) and during (March to April 2020) pandemic
Impact of the COVID-19 pandemic on the activities of the cardiology service of the Ignace Deen
National Hospital of the Conakry CHU. Impact of the COVID-19 pandemic on the activities of
the cardiology service of the Ignace Deen National Hospital of the Conakry CHU Impact of the
COVID-19 pandemic on the activities of the cardiology service of the Ignace Deen National
Hospital of the Conakry CHU
Keywords: Impact, COVID-19, Activities, Cardiology, Ignace Deen
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APPENDIX B: APPLICATION OF PUBLIC HEALTH COMPETENCIES
MPH Foundational Competency
MPHF4. Interpret results of data analysis for public health research, policy or practice
The findings obtained from the descriptive analysis and any undertaken tests were placed in
context to discuss potential lessons learned regarding malaria control in emergencies.
MPH Concentration Competencies: Epidemiology
EPIMPH1. Determine the strengths and weaknesses of the scientific literature and synthesize the
evidence to inform public health practice.
Findings from this work will be compared with related examples from the literature to improve
malaria control programs in the target population based on the literature.
EPIMPH4. Utilize analytical approaches to describe, summarize and interpret epidemiologic
data.
Time series descriptive analysis helped me analyze the monthly collected quantitative data and
describe malaria cases over time. In malaria control programs, the proc means procedure helps
evaluate the effectiveness of the program by tracking changes in key indicators. These different
statistical methods helped me become more adept at describing, summarizing, and interpreting
epidemiological data related to specific health issues. My present research and analytical skills
have also enhanced my ability to make decisions and address public health needs that could
affect large populations of people in my future career.
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